Lantern Pharma (LTRN) Earnings Date & Reports

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LTRN is expected to report earnings to rise 5.56% to -37 cents per share on August 12

Lantern Pharma LTRN Stock Earnings Reports

Q2'26

Est.

$-0.38

Q4'25

Beat

by $0.18

Q3'25

Beat

by $0.05

Q2'25

Beat

by $0.13

Q4'24

Beat

by $0.05

The last earnings report on March 30 showed earnings per share of -36 cents, beating the estimate of -54 cents. With 132.96K shares outstanding, the current market capitalization sits at 49.25M.

View a ticker or compare two or three

Compare

LTRN

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for LTRN